Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki et al. · The Lancet Oncology · 2015 · 2K citations · Full text

Medicine, Oncology, Radiation Oncology +17

Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer

Kiyoyuki Furuse, Masahiro Fukuoka, Masaaki Kawahara et al. · Journal of Clinical Oncology · 1999 · 1.5K citations

Medicine, Oncology, Radiation Oncology +12

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

C. Schaake-Koning, Walter Van den Bogaert, Otilia Dalesio et al. · New England Journal of Medicine · 1992 · 1.3K citations

Medicine, Oncology, Radiation Oncology +12

Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

Walter J. Curran, Rebecca Paulus, Corey J. Langer et al. · JNCI Journal of the National Cancer Institute · 2011 · 1.2K citations · Full text

Medicine, Oncology, Radiation Oncology +13

PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non–Small-Cell Lung Cancer

Suresh Senan, Anthony Brade, Lu-hua Wang et al. · Journal of Clinical Oncology · 2016 · 437 citations · Full text

Medicine, Oncology, Radiation Oncology +14